Serum hepcidin levels related to interlukin-6 in patients with acute myeloid leukemia before and after treatment

Serum hepcidin levels related to interlukin-6 in patients with acute myeloid leukemia before and after treatment

BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous malignant disease of hematopoietic tissue. It is characterized by accumulation of abnormal blast cells mainly in bone marrow. Hepcidin is a small bioactive peptide hormone produced in many tissues mainly by the liver, macrophage, and adipoc...

Full description

Bibliographic Details
Main Authors: Khitam Abdulwahhab Ali, Hiba Ammar Mohammad, Alaadin Sahham Naji, Alaa Fadhil Alwan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Iraqi Journal of Hematology
Subjects:
acute myeloid leukemia
hepcidin
interleukin-6
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=1;spage=76;epage=82;aulast=Ali

Internet

http://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=1;spage=76;epage=82;aulast=Ali

Similar Items